FDA Adverse Event Death Summary report: N

SWAN GANZ UNKNOWN

MDR report key: 20075781 · Received August 27, 2024

Report

Report Number
2015691-2024-06469
Event Type
Death
Date Received
August 27, 2024
Date of Event
July 16, 2024
Report Date
August 27, 2024
Manufacturer
EDWARDS LIFESCIENCES PR
Product Code
DYG
UDI-DI
00690103198430
PMA / PMN Number
K193466
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

IT IS UNKNOWN OF THE MODEL AND LOT NUMBER AND IF THE PRODUCT WILL BE RETURNED, BUT FOLLOW UP IS NOT POSSIBLE AS THE MEDWATCH REPORT WAS ANONYMOUS. IF THE DEVICE IS RETURNED A SUPPLEMENTAL REPORT WILL BE SUBMITTED WITH ADDITIONAL INFORMATION AND EVALUATION RESULTS. ADDITIONAL PRODUCT CODES ARE DQE AND DQO. PER THE INSTRUCTIONS FOR USE, PULMONARY ARTERY PERFORATION IS A KNOWN POTENTIAL ADVERSE EVENT WHICH HAS BEEN IDENTIFIED AS A POSSIBLE COMPLICATION OF THE USE OF PULMONARY ARTERY CATHETERS, SUCH AS THE SWAN GANZ. THERE ARE MULTIPLE PATIENT AND PROCEDURAL FACTORS THAT ALONE OR IN COMBINATION CAN CAUSE OR CONTRIBUTE TO PULMONARY ARTERY PERFORATION, INCLUDING PULMONARY HYPERTENSION, ADVANCED AGE, CARDIAC SURGERY WITH HYPOTHERMIA AND ANTICOAGULATION, DISTAL CATHETER TIP MIGRATION, ARTERIOVENOUS FISTULA FORMATION AND OTHER VASCULAR TRAUMAS. EXTREME CARE SHOULD THEREFORE BE EXERCISED DURING THE MEASUREMENT OF PULMONARY ARTERY WEDGE PRESSURE IN PATIENTS WITH PULMONARY HYPERTENSION. IN ALL PATIENTS, BALLOON INFLATION SHOULD BE LIMITED TO TWO RESPIRATORY CYCLES, OR 10 TO 15 SECONDS. A CENTRAL LOCATION OF THE CATHETER TIP NEAR THE HILUM OF THE LUNG MAY PREVENT PULMONARY ARTERY PERFORATION. EARLY CLINICAL SYMPTOMS OF A PULMONARY ARTERY PERFORATION INCLUDE HEMOPTYSIS OF BRIGHT RED BLOOD AND OR HYPOTENSION. IN THIS CASE, THERE WAS NO ALLEGATION OR INDICATION A DEVICE MALFUNCTION CONTRIBUTED TO THIS ADVERSE EVENT. THE REPORT STATED THAT THE PHYSICIAN ADVANCED THE MEDTRONIC GUIDEWIRE TO THE PULMONARY ARTERY AND THEN ADVANCED THE SWAN GANZ CATHETER OVER THE GUIDEWIRE. THE IFU INSTRUCTS TO USE THE MODIFIED SELDINGER TECHNIQUE TO INSERT THE GUIDEWIRE. THE TECHNIQUE REQUIRES THAT THE CATHETER IS ADVANCED, AND THE GUIDEWIRE IS REMOVED BEFORE ENTERING THE HEART, WHICH IS STANDARD CLINICAL PRACTICE. THE REPORT INDICATES THAT THE ROOT CAUSE IS NOT LIKELY TO BE RELATED TO THE SWAN GANZ DEVICE. THE IFU HAS BEEN REVIEWED AND NO INADEQUACIES HAVE BEEN IDENTIFIED WITH REGARDS TO WARNINGS, CONTRAINDICATIONS, AND THE DIRECTIONS OR CONDITIONS FOR THE SUCCESSFUL USE OF THE DEVICE. COMPLAINT HISTORIES FOR ALL REPORTED EVENTS ARE REVIEWED THROUGH TRENDING ON A MONTHLY BASIS AND CONTINUE TO BE MONITORED FOR ANY UNFAVORABLE TRENDS AND DOCUMENTED AS PART OF THIS MONTHLY REVIEW. NO CORRECTIVE OR PREVENTATIVE ACTIONS ARE REQUIRED AT THIS TIME.

Description of Event or Problem · 0

IT WAS REPORTED FROM AN ANONYMOUS FACILITY THAT A PATIENT DIED DURING A RIGHT HEART CATHETERIZATION PRIOR TO A CARDIOMEMS IMPLANT PROCEDURE. THE PHYSICIAN INSERTED A MEDTRONIC 0.18 NITREX GUIDEWIRE AND ADVANCED THE GUIDEWIRE TO THE PULMONARY ARTERY AND USED A SWAN GANZ CATHETER OVER THE GUIDEWIRE. THE PATIENT COUGHED A FEW TIMES, AND THE RIGHT HEART CATHETERIZATION WAS CONTINUED. THE PATIENT THEN EXPERIENCED HEMOPTYSIS AND RESUSCITATION WAS ATTEMPTED AS THE PATIENT WAS DETERIORATING. A THORACOTOMY WAS COMPLETED IN AN ATTEMPT TO STOP THE BLEEDING, BUT THE PATIENT DIED IN THE CATH LAB. CARDIOMEMS SENSOR WAS NOT OPENED OR INSERTED INTO THE BODY. CAUSE OF DEATH WAS NOT SPECIFICALLY IDENTIFIED, BUT THE PHYSICIAN BELIEVED THAT THERE WAS A PERFORATION, HOWEVER ONE COULD NOT BE IDENTIFIED. IT WAS NOTED THAT THE PATIENT ALSO EXPERIENCED CARDIAC ARREST, BLEEDING, AND RESPIRATORY ARREST.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
953854 SWAN GANZ UNKNOWN CATHETER, FLOW DIRECTED DYG EDWARDS LIFESCIENCES PR SWAN GANZ UNKNOWN 00690103198430

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Death| O